The Norwegian "iCanCope With Pain" App

Sponsor
University of Agder (Other)
Overall Status
Completed
CT.gov ID
NCT03551977
Collaborator
The Hospital for Sick Children (Other)
112
1
2
6.5
17.1

Study Details

Study Description

Brief Summary

Background: Research evidence shows that prevalence of pain in adolescents is increasing and is therefore recognized as a growing health problem. Psychological interventions delivered remotely through the internet may reduce intensity or severity of pain among children and adolescents with chronic pain. The iCanCope with Pain program is an existing web- and mobile-based self-management program, which is developed as a multi-center study funded by the Canadian Institutes of Health Research and is based on identified health care needs and current best practices for pain self-management.

Objectives: The primary objectives are to describe the translation and cultural adaptation of the Norwegian version of the iCanCope with Pain mobile application and evaluate the effect in an upcoming randomized controlled trail with adolescents with chronic pain.

Study sample: 16-19-year-old adolescents with self-declared persistent and/or chronic pain. Recruited from high schools in Southern Norway.

Theoretical framework: Cognitive behavioral therapy (CBT) is explained by an integration of behavioral and cognitive theories of human behavior and psychopathology and is often the preferred treatment of choice for adolescents with different health disorders. The theoretical framework of CBT is integrated in the iCanCope with Pain app in terms of five components. The intervention group will receive the app with all five components: (I) symptom trackers for pain, sleep, mood, physical, and social function; (II) goal setting to improve pain and function; (III) coping toolbox of pain self-management strategies; (IV) social support; (V) age-appropriate pain education. The control group will receive the app with only the first self-registration component (I) symptom trackers for pain, sleep, mood, physical, and social function.

Methods: Both qualitative and quantitative data will be gathered for evaluating the Norwegian version of the iCanCope with Pain app. Usability testing are assessed in both laboratory settings and in field using observation, interviews and questionnaires, which provide necessary information for an upcoming randomized controlled trail (RCT). Outcomes will in the RCT be measured at baseline (mid-April) and after an 8 weeks intervention (mid-June).

The study is part of a PhD project.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: iCanCope with Pain
  • Behavioral: iCanCope with Pain control
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
112 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
A single-centre, RCT study design with two arms, one control group (N=56) and one intervention group (N=56).A single-centre, RCT study design with two arms, one control group (N=56) and one intervention group (N=56).
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Cultural Adaptation and Evaluation of the "iCanCope With Pain" App Among Norwegian Adolescents Living With Pain
Actual Study Start Date :
Nov 28, 2017
Actual Primary Completion Date :
Jun 15, 2018
Actual Study Completion Date :
Jun 15, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention group

The intervention group will receive the iCanCope with Pain app with all five components: (I) symptom trackers for pain, sleep, mood, physical, and social function; (II) goal setting to improve pain and function; (III) coping toolbox of pain self-management strategies; (IV) social support; (V) age-appropriate pain education

Behavioral: iCanCope with Pain
The participants are free to use the Norwegian iCanCope with Pain app as much as they want during the 8 week intervention period. The only support available is technical support.

Active Comparator: Control group

The control group will receive the iCanCope with Pain control app with only the first self-registration component (I) symptom trackers for pain, sleep, mood, physical, and social function.

Behavioral: iCanCope with Pain control
The participants are free to use the Norwegian iCanCope with Pain control app as much as they want during the 8 week intervention period. The only support available is technical support.

Outcome Measures

Primary Outcome Measures

  1. Pain [Baseline and 8 weeks (post-intervention)]

    Change in total score of the Lubeck Pain Questionnaire (LPQ) and the subscale pain intensity using Visual Analogue Scale (VAS) from 0-10. Lower values at post-intervention represent a better outcome.

  2. Quality of life [Baseline and 8 weeks (post-intervention)]

    Change in total score of the Kidscreen 52 Questionnaire. Higher values at post-intervention represent a better outcome.

Secondary Outcome Measures

  1. Physical activity [Baseline and 8 weeks (post-intervention)]

    Change in total score of the International Physical Activity Questionnaire (IPAQ). Higher values at post-intervention represent a better outcome.

  2. Coping [Baseline and 8 weeks (post-intervention)]

    Change in total score of the General Self-Efficacy Questionnaire Short Version (GSEQ). Higher values at post-intervention represent a better outcome.

  3. Social participation [Baseline and 8 weeks (post-intervention)]

    Change in total score of school absence (General Information Questionnaire). Lower values at post-intervention represent a better outcome.

  4. Over-The-Counter (OTC) analgesics [Baseline and 8 weeks (post-intervention)]

    Change in total score of OTC analgesics consumption (General Information Questionnaire). Lower values at post-intervention represent a better outcome.

  5. Perceived social support from friends [Baseline and 8 weeks (post-intervention)]

    Change in total score of the Perceived Social Support from friends Questionnaire (PSS). Higher values at post-intervention represent a better outcome.

  6. Pain self-efficacy questionnaire [Baseline and 8 weeks (post-intervention)]

    Change in total score of the Pain Self-Efficacy Questionnaire (PSEQ). Higher values at post-intervention represent a better outcome.

  7. Anxiety and depression [Baseline and 8 weeks (post-intervention)]

    Change in total score of the Hospital Anxiety and Depression Scale Questionnaire (HADS). Lower values at post-intervention represent a better outcome.

  8. Global impression of change [After 8 weeks (post-intervention)]

    Change in Patients' Global Impression of Change Scale (PGIC) from 1-7. Higher values at post-intervention represent a better outcome.

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years to 19 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. 16-19-year-old adolescents

  2. with persistent and/or chronic pain, weekly suffered and lasting 3 months or more based on subjective reporting

  3. be able to read and understand Norwegian

  4. have their own smartphone.

Exclusion Criteria:
  1. Adolescents with cognitive disability or diseases, because of the risk of not correctly understanding the iCanCope with Pain program via self-report, goal setting and/or library reading.

  2. Adolescents that have participated in the usability testing of the Norwegian iCanCope with Pain app

  3. Adolescents with diagnoses from a pathological or medical origin (e.g hematology/oncology patients) will also be excluded because the program was not specifically designed for these pain groups.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Erik Grasaas Kristiansand Norway 4633

Sponsors and Collaborators

  • University of Agder
  • The Hospital for Sick Children

Investigators

  • Principal Investigator: Kristin Haraldstad, PhD, UiA

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Erik Grasaas, Principal Investigator, University of Agder
ClinicalTrials.gov Identifier:
NCT03551977
Other Study ID Numbers:
  • 1310 63221
First Posted:
Jun 11, 2018
Last Update Posted:
Oct 15, 2018
Last Verified:
Oct 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Oct 15, 2018